A new study shows that binge drinkers have increased levels of a biomarker molecule — microRNA-21 — that may contribute to poor vascular function. Researchers believe that measurements of microRNA-21 could help determine if a patient with a history of binge drinking is at risk of developing cardiovascular disease.
NYU Langone Hospital – Brooklyn has appointed four highly skilled heart specialists to integrate new technology and advances in research with the care delivered in the community.
Billions of US taxpayer dollars have been invested in Africa over the past 15 years to improve care for millions suffering from the HIV/AIDS epidemic; yet health systems on the continent continue to struggle. What if the investments and lessons learned from HIV could be used to improve care for those with other serious chronic conditions? With this question in mind, researchers from Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, along with investigators and clinicians based in Uganda, borrowed an HIV/AIDS innovation to seek inroads against rheumatic heart disease in sub-Saharan Africa.
The Society of Thoracic Surgeons (STS), the Society of Cardiovascular Anesthesiologists (SCA), and the American Society of ExtraCorporeal Technology (AmSECT) released a new clinical practice guideline that includes major recommendations for the use of blood thinning medication (anticoagulants) during heart surgery.
Researchers have data that diabetes impairs removal of dead heart-muscle cells by macrophages after heart attacks, and that exosomes can improve this removal. Impaired removal may be the reason diabetes increases the risk for cardiovascular disease, including heart failure.
The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” on Wednesday, February 7, 2018 in New York City. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing attendees a deeper understanding of diabetes and its connection with cardiovascular disease.
Doctors have long treated heart attacks, improved asthma symptoms, and cured impotence by increasing levels of a single molecule in the body: nitric oxide. The tiny molecule can change how proteins function. But new research featured in Molecular Cell suggests supplementing nitric oxide—NO—is only the first step. Researchers have discovered previously unknown enzymes in the body that convert NO into “stopgap” molecules—SNOs—that then modulate proteins. The newly discovered enzymes help NO have diverse roles in cells. They may also be prime therapeutic targets to treat a range of diseases.
A longtime blood test that measures the likelihood of a cardiac event has become more sensitive and more precise. Why doctors and patients should be cautiously optimistic.
A rare glimpse into the prior authorization requirements implemented by public and private insurance providers across the country has found substantial administrative burden for a new class of medications for patients with high cholesterol that places them at high risk for heart attack or stroke. So-called proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are self-injected medications approved for individuals with a genetic condition called familial hypercholesterolemia (FH) and those with atherosclerotic cardiovascular disease (ASCVD) who have high cholesterol despite receiving traditional statin medications and other treatments. Results of the study are published in Circulation: Cardiovascular Quality and Outcomes.
“Decorating” cardiac stem cells with platelet nanovesicles can increase the stem cells’ ability to find and remain at the site of heart attack injury and enhance their effectiveness in treatment.
One of the NIH’s training awards, the highly selective Kirschstein fellowship is conferred to top U.S. graduate students in health science-related fields.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
According to new research in the American Heart Association journal, Circulation: Cardiovascular Quality and Outcomes, almost 5 percent of heart failure risk was connected to neighborhood factors.
Jacobs Medical Center at UC San Diego Health in La Jolla recently received certification from the Joint Commission to be a Comprehensive Stroke Center. This certification is in addition to the existing accreditation at UC San Diego Medical Center in Hillcrest. This expansion makes UC San Diego Health the only health system in San Diego County to have two access points for comprehensive stroke care.
Exercise can reverse damage to sedentary, aging hearts and help prevent risk of future heart failure – if it’s enough exercise, and if it’s begun in time, according to a new study by cardiologists at UT Southwestern and Texas Health Resources.
On Jan. 1, Medicare began covering a new noninvasive test for heart disease called FFR-CT. "Medicare coverage is a major milestone," said Loyola Medicine cardiologist Mark Rabbat, MD. "Millions of Americans now can potentially benefit from this game-changing technology."
Recently, researchers have been studying diseases with a new approach: small, organ-on-a-chip devices that mimic the functions of human organs, serving as potentially cheaper and more effective tools. Now researchers have built a device that's especially good for modeling atherosclerosis. In this week’s APL Bioengineering, researchers illustrate how the new device can be used to study important inflammatory responses in cells that line the vessel in ways that could not be done in animal models.
In a direct comparison study, Johns Hopkins researchers have added to evidence that a newer method of calculating so-called “bad cholesterol” levels in the blood is more accurate than the older method in people who did not fast before blood was drawn.
Thanks, in part, to pigs at the University of Wisconsin–Madison’s Arlington Agricultural Research Station, scientists now are catching up on understanding the roots of calcific aortic valve disease (CAVD).
An FDA-approved drug to treat high blood pressure seems to extend life span in worms via a cell signaling pathway that may mimic caloric restriction.
A long-term look at heart attack care and spending in America in the 21st Century shows more survival, more spending, and more variation between hospitals on both scores. And while spending on rapid angioplasty appears to be paying off, a lot of the dollars spent in the six months after a heart attack aren’t making a difference in the long-term death rate.
Varenicline, one of the most commonly prescribed drugs for helping people quit smoking, may put them at higher risk for a cardiovascular event, according to new research published online in the American Journal of Respiratory and Critical Care Medicine.
Hackensack Meridian Health Hackensack University Medical Center is among the first in the tri-state region and the first in Bergen County, New Jersey to offer an innovative new treatment that prevents stroke in patients with blocked carotid arteries, the major blood vessels that deliver blood to the brain.
A new video by the University of Warwick highlights a bitter side to our sugar consumption at Christmas. The short film highlights how excessive consumption of sugar can affect our health – and how the sugar trade in the past and today has caused inequality and bloodshed.Today Britons eat too much sugar, on average 10 per cent of our daily calories come from sugar which is equivalent to 60 g per day; however WHO guidelines state that adults should eat no more than of 30g of sugar a day which is just five per cent of our daily calorific intake.
A clinical decision support application developed by Intermountain Healthcare researchers that more quickly identifies when heart failure becomes advanced and a heart patient’s care needs have changed is successful in helping to improve patient’s quality of live and longevity, according to a new study.
Toledo heart surgeon is first in the U.S. to perform new heart valve replacement surgery. Heart valve disease affects about five million Americans each year.
Penn Medicine’s Innovation Accelerator Program, now in its fifth year, has announced funding for four new projects aimed at addressing disparities to improve health care delivery and patient outcomes.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered how high glucose levels - whether caused by diabetes or other factors - keep heart cells from maturing normally. Their findings help explain why babies born to women with diabetes are more likely to develop congenital heart disease.
NYU Langone launches a new heart transplant program.
Large national study shows the life-saving potential of coordinating EMS, hospital responses
A new study by NYU College of Global Public Health and the University of Michigan finds that the “obesity paradox” is not present among people with new cases of cardiovascular disease.
Study of Electrocardiogram Readings in National Basketball Association (NBA) Players Highlights Value of Sport-Specific Normative Data and Guidelines. The findings were published on Dec. 6 in JAMA Cardiology.
Using zebrafish mutants in four different estrogen receptors, Daniel Gorelick has found a novel mechanism of estrogen action on heart physiology. Broader use of the mutants, he says, may have significant implications for studies of estrogenic environmental endocrine disruptors.
High blood pressure (hypertension) is redefined for the first time in 14 years by the American College of Cardiology and American Heart Association Task Force on Clinical Practice Guidelines.
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia State University has shown.
A reindeer with a red glowing nose. A heart, two sizes two small, that suddenly grows three sizes. A trip to the past and to the future — all in one night. Researchers dug deep into their reserves of scientific expertise to explain how these inexplicable plot lines in holiday classics just might be (almost) possible:
Led by researchers in the Smith Center for Outcomes Research in Cardiology at Beth Israel Deaconess Medical Center (BIDMC), the large-scale analysis determined that 30 percent of readmissions following peripheral revascularization were related to complications associated with the procedure, while differences in hospital quality accounted only modestly for readmission risk.
Hackensack Meridian Health Riverview Medical Center in Red Bank, NJ is pleased to welcome vascular surgeon, Habib Khan, M.D., to the medical staff. Dr. Khan specializes in vascular surgery especially minimally invasive vascular surgery and joined the Hackensack Meridian Health Cardiovascular Network in August 2015, practicing at Jersey Shore University Medical Center in Neptune, NJ and Bayshore Medical Center in Holmdel, NJ, where he was named Physician of the Year in 2017.
BOSTON – (November 29, 2017) – Scientists at Joslin Diabetes Center have taken another step toward solving a long-standing puzzle about heart health in type 2 diabetes, with a finding that eventually may point towards more personalized patient care.People with type 2 diabetes, who are at least twice as likely to develop cardiovascular disease (CVD) as people without the condition, generally can reduce their risks by careful controlling their glycemic (blood glucose) levels.
a powerful new computer model replicates the biological activity within the heart that precedes sudden cardiac death.
Physician-researchers from the Cardiac Center at Children’s Hospital of Philadelphia recently presented new findings on pediatric cardiovascular disease at the American Heart Association’s Scientific Sessions 2017 in Anaheim, Calif. Among many abstracts presented were research on racial disparities in bystander CPR methods in children with sudden cardiac arrest, and findings that children with hypertrophic cardiomyopathy may be at risk for sudden cardiac death.
People who have lived though natural disasters such as Hurricane Harvey are under a great amount of stress putting their lives back together. A cardiologist tells us that this type of stress, in a roundabout way, can do damage to the heart.
The final results of the DAWN study, published in The New England Journal of Medicine, show that select patients with stroke caused by a blood clot can be effectively treated with a procedure to remove the clot mechanically – and that this can be done up to 24 hours after the onset of symptoms.
Less than one per cent of UK children born with congenital heart disease are enrolled in clinical trials looking to improve treatments, research by the University of Birmingham has found.
New research by UT Southwestern cardiologists counters long-held beliefs that hospitals performing greater numbers of heart valve surgeries have better outcomes.
A study of more than 400 adults with prehypertension, or stage 1 high blood pressure, found that combining a low-salt diet with the heart-healthy DASH diet substantially lowers systolic blood pressure — the top number in a blood pressure test — especially in people with higher baseline systolic readings.
People with both HIV and risk factors for heart disease and stroke were less likely to be treated with cholesterol-lowering statin drugs and aspirin than patients without HIV.
Infants with various forms of congenital heart disease require a stable source of blood flow to their lungs in order to survive until a more definitive operation can be performed. In a recent study, pediatric researchers compared two methods to provide that flow: a shunt to reroute blood and an implanted stent to maintain an open path for blood flow. They found that stents were preferable for selected patients.
Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.
By studying the genetic makeup of people who maintain clear arteries into old age, researchers led by UNC’s Jonathan Schisler, PhD, have identified a possible genetic basis for coronary artery disease (CAD), as well as potential new opportunities to prevent it.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right